Free Trial
→ A grave, grave error. (From Porter & Company) (Ad) Buy VRDN Stock  Free VRDN Stock Alerts

Viridian Therapeutics (VRDN) SEC Filings & 10K Form

Viridian Therapeutics logo
$13.57 -0.10 (-0.73%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$13.56 -0.01 (-0.07%)
As of 05/23/2025 06:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Viridian Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/20/2025
6:16 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
10:44 AM		Kynam Capital Management, LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G
05/06/2025
6:55 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2025
6:28 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
6:54 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEF 14A
04/25/2025
6:57 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
04/25/2025
6:59 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form ARS
04/11/2025
4:15 PM		COMMODORE CAPITAL LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G
04/09/2025
3:19 PM		Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2025
3:26 PM		Ajer Jeffrey Robert (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
6:12 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:27 PM		Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:36 PM		Tripuraneni Radhika (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:17 PM		CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/12/2025
3:19 PM		CAIN CHRISTOPHER W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:12 PM		Harmon Seth (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:13 PM		Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:14 PM		Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
8:17 PM		Tousignant Jennifer (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
5:09 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
03/03/2025
3:35 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/03/2025
6:33 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
6:11 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
5:05 PM		Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SCHEDULE 13G/A
12/16/2024
6:22 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:52 PM		Venrock Healthcare Capital Partners III, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
4:53 PM		Venrock Opportunities Fund, L.P. (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:50 PM		PERCEPTIVE ADVISORS LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/14/2024
3:33 PM		Paradigm Biocapital Advisors LP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
11/12/2024
6:15 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2024
6:15 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/18/2024
11:33 AM		STATE STREET CORP (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13G/A
09/30/2024
6:12 PM		Beetham Thomas W. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:10 PM		Mahoney Stephen F. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
8:00 PM		Fairmount Funds Management LLC (Filed by)
Viridian Therapeutics, Inc.\DE (Subject)
Viridian Therapeutics (Subject)
Form SC 13D/A
09/17/2024
8:00 PM		Fairmount Funds Management LLC (Reporting)
Fairmount Healthcare Fund II GP LLC (Reporting)
Fairmount Healthcare Fund II L.P. (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
5:07 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/12/2024
4:25 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
3:28 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 424B5
09/10/2024
6:11 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2024
7:25 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Watch This Robotics Demo Before July 23rd (Ad)

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."

Click here to watch the demo…
08/08/2024
7:01 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:31 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
3:25 PM		Gheuens Sarah (Reporting)
Viridian Therapeutics, Inc.\DE (Issuer)
Viridian Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
3:16 PM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
7:05 AM		Viridian Therapeutics, Inc.\DE (Filer)
Viridian Therapeutics (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VRDN) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
Banks aren’t ready for this altcoin—are you?
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...
Crypto 101 Media | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored